Funds Holding Sarepta Therapeutics Inc

Also showing items for ETFS Holding Sarepta Therapeutics Inc

 
Funds Holding Sarepta Therapeutics Inc top ^
  • Holdings: Celldex Therapeutics, Inc., Aegerion Pharmaceuticals, Inc., DexCom, Inc., SodaStream International Ltd., Sarepta Therapeutics Inc
  • Category: Small Growth
  • Morningstar Rating: 4 Stars
Sign-up for lmiyx investment picks

 
Stock Quotes for Sarepta Therapeutics Inc top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for srpt investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for srpt investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for ab3a investment picks

 
News Articles for Sarepta Therapeutics Inc top ^
2013/2/4
http://media.marketwire.com/attachments/201207/48809_SareptaTherapeutics.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=981220&ProfileId=051205&sourceType=1 CAMBRIDGE, MA --
Sign-up for Sarepta Therapeutics to Present Company Overview at the Leerink Swann Global Healthcare Conference investment picks
2013/1/30
http://media.marketwire.com/attachments/201207/48809_SareptaTherapeutics.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=980302&ProfileId=051205&sourceType=1 CAMBRIDGE, MA --
Sign-up for Statement From Sarepta Therapeutics on Stock Volatility investment picks
2013/2/21
http://media.marketwire.com/attachments/201207/48809_SareptaTherapeutics.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=988197&ProfileId=051205&sourceType=1 CAMBRIDGE, MA --
Sign-up for Sarepta Therapeutics to Present at Cowen & Company 33rd Annual Healthcare Conference investment picks
2013/2/20
http://media.marketwire.com/attachments/201207/48809_SareptaTherapeutics.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=987894&ProfileId=051205&sourceType=1 CAMBRIDGE, MA --
Sign-up for Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2012 Financial Results and Corporate Update on March 7, 2013 investment picks
2013/4/15
http://media.marketwire.com/attachments/201207/48809_SareptaTherapeutics.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1007333&ProfileId=051205&sourceType=1 CAMBRIDGE, MA --
Sign-up for Sarepta Therapeutics Announces FDA Will Consider Accelerated Approval for Eteplirsen After Further Review of Data on Dystrophin and Clinical Outcomes investment picks
2013/4/18
http://media.marketwire.com/attachments/201207/48809_SareptaTherapeutics.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1008751&ProfileId=051205&sourceType=1 CAMBRIDGE, MA --
Sign-up for Sarepta Therapeutics to Present Company Overview at the Needham Annual Healthcare Conference investment picks
2013/4/26
http://media.marketwire.com/attachments/201207/48809_SareptaTherapeutics.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1011266&ProfileId=051205&sourceType=1 CAMBRIDGE, MA --
Sign-up for Sarepta Therapeutics to Announce First Quarter 2013 Financial Results and Corporate Update on May 9, 2013 investment picks
2013/5/9
http://media.marketwire.com/attachments/201207/48809_SareptaTherapeutics.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1015518&ProfileId=051205&sourceType=1 CAMBRIDGE, MA --
Sign-up for Sarepta Therapeutics Announces First Quarter 2013 Financial Results and Recent Corporate Developments investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Funds Holding Sarepta Therapeutics Inc
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Sappi, Ltd.  |  Next: Funds Holding Sarin Technologies Ltd.